| Category: | Doctor, Health, |
|---|---|
| Address: | 100 Bayer Blvd, Whippany, NJ 07981, USA |
| Postal code: | 07981 |
| Phone: | (888) 842-2937 |
| Website: | https://www.stivarga-us.com/contact-us/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Stivarga, use the form below and your opinion, advice or comment will appear in this space.
(1-888-842-2937) For help with questions about REACH Eligible patients prescribed STIVARGA can turn to REACH (Resources for Expert Assistance and Care Helpline), a free support program providing you with information about your therapy as well as your financial assistance options.
For more information, go to www.STIVARGA-US.com or call 1-888-842-2937. This Patient Information has been approved by the U.S. Food and Drug Administration. 4/2017 Indications
Important contact information For STIVARGA Product Inquiries: Bayer. 100 Bayer Blvd. Whippany, NJ 07981. PHONE: 1-888-84Bayer (1-888-842-2937) Click here to report an adverse event.
For more information, go to www.STIVARGA-US.com or call 1-888-842-2937. This Patient Information has been approved by the U.S. Food and Drug Administration. Revised: 4/2017
For STIVARGA Product Inquiries: Bayer. 100 Bayer Blvd. Whippany, NJ 07981. PHONE: 1-888-84Bayer (1-888-842-2937) For STIVARGA Patient Support: STIVARGA REACH Program. PHONE: 1-866-639-2827. 24 hours a day, 365 days a year
For more information call (888) 842-2937 or visit Stivarga-US.com. Topics: Bladder/Kidney/Other Urologic Cancers Colorectal And Other GI Cancers Miscellaneous Urogenital Disorders Oncology ...
Stivarga is a kinase inhibitor indicated for the treatment of patients with ... HealthCare Pharmaceuticals Inc. at 1-888-842-2937 or FDA at 1-800-
Stivarga is a kinase inhibitor indicated for the treatment of patients with: ... HealthCare Pharmaceuticals Inc. at 1-888-842-2937 or FDA at 1-800-FDA-1088 or .
See full prescribing information for STIVARGA. STIVARGA® (regorafenib) tablets, for oral use ... HealthCare Pharmaceuticals Inc. at 1-888-842-2937 or FDA at 1-800-
STIVARGA INDICATIONS. STIVARGA is indicated for the treatment of patients with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type, an anti-EGFR therapy.